Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/8d/b8/0f/8db80f81-2247-4672-914d-289f9cb6f61b/mza_3544939216694081436.jpg/600x600bb.jpg
The Long Run with Luke Timmerman
Timmerman Report
187 episodes
1 week ago
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Show more...
Science
RSS
All content for The Long Run with Luke Timmerman is the property of Timmerman Report and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Show more...
Science
https://i1.sndcdn.com/avatars-000334687557-gwdmq9-original.jpg
Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA
The Long Run with Luke Timmerman
1 hour 10 minutes 45 seconds
5 months ago
Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA
John Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.
The Long Run with Luke Timmerman
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.